Tasly Pharmaceutical Group
Tasly Pharmaceutical Group Co Ltd is a major Chinese pharmaceutical manufacturing enterprise headquartered in Tianjin, China. The company specializes in the research, development, manufacturing, and distribution of traditional Chinese medicines, modern botanical drugs, biopharmaceuticals, and chemical prescription formulations targeting cardiovascular, cerebrovascular, and oncological diseases. Principal revenue is derived through wholesale manufacturing sales of proprietary pharmaceutical products to hospitals, medical institutions, and pharmacies across China. Tasly Pharmaceutical Group is publicly listed on the Shanghai Stock Exchange.
2 of the funds FundTelligence covers report a position in Tasly Pharmaceutical Group.
- Legal name
- Tasly Pharmaceutical Group Co Ltd
- Sector
- Health Care
- Country
- China
- Funds holding it
- 2
Funds holding Tasly Pharmaceutical Group
- Handelsbanken Global Index Criteria — Handelsbanken · 0.01 % (full portfolio disclosed, September 2026)
- Handelsbanken Emerging Markets Index — Handelsbanken · 0.0 % (full portfolio disclosed, September 2026)